A substudy of the CANTOS trial suggests a causal relationship between interleukin-6 receptor activation and coronary artery disease. Might IL-6 receptor antagonists provide clinical benefit in CAD?
European Heart Journal
Original Article: CANTOS: A Seductive Song With Several Verses